Disclosures for "Sensitivity of 1st EEG in Detecting Generalized Spike and Wave Activity in Absence Epilepsy"
-
An immediate family member of Mr. Fountain has received personal compensation for serving as an employee of Acumen Pharmaceuticals. An immediate family member of Mr. Fountain has received personal compensation for serving as an employee of Hexokine Therapeutics. An immediate family member of Mr. Fountain has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Acumen Pharmaceuticals. An immediate family member of Mr. Fountain has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Hexokine Therapeutics. An immediate family member of Mr. Fountain has stock in Hexokine Therapeutics. An immediate family member of Mr. Fountain has stock in Acumen Pharmaceuticals.
-
Dr. Fountain has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amylyx. Dr. Fountain has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Coda. Dr. Fountain has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Fountain has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Fountain has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. Dr. Fountain has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Fountain has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BrainStorm. Dr. Fountain has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Shackleford. Dr. Fountain has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Acumen. Dr. Fountain has stock in Hexokine.